These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11596853)

  • 21. Symptom outcome 1 year after admission to an early psychosis program.
    Addington J; Leriger E; Addington D
    Can J Psychiatry; 2003 Apr; 48(3):204-7. PubMed ID: 12728745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
    Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of schizoaffective disorder and schizophrenia with mood symptoms.
    Levinson DF; Umapathy C; Musthaq M
    Am J Psychiatry; 1999 Aug; 156(8):1138-48. PubMed ID: 10450252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
    Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
    Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal ganglia volumetric changes in psychotic spectrum disorders.
    Liu C; Cao B; Yu R; Sim K
    J Affect Disord; 2019 Aug; 255():150-157. PubMed ID: 31153051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review and meta-analysis of suicidality in psychotic disorders: Stratified analyses by psychotic subtypes, clinical setting and geographical region.
    Álvarez A; Guàrdia A; González-Rodríguez A; Betriu M; Palao D; Monreal JA; Soria V; Labad J
    Neurosci Biobehav Rev; 2022 Dec; 143():104964. PubMed ID: 36403792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.
    Fond G; Boyer L; Favez M; Brunel L; Aouizerate B; Berna F; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq ; Faget C; Gabayet F; Laouamri H; Lancon C; Le Strat Y; Misdrahi D; Rey R; Passerieux C; Schandrin A; Schurhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Pelissolo A;
    Psychopharmacology (Berl); 2016 Feb; 233(4):571-8. PubMed ID: 26630993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features.
    Pini S; Cassano GB; Dell'Osso L; Amador XF
    Am J Psychiatry; 2001 Jan; 158(1):122-5. PubMed ID: 11136644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity.
    Nakonezny PA; Byerly MJ; Rush AJ
    Psychiatry Res; 2008 Jan; 157(1-3):259-63. PubMed ID: 17935793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia.
    Tsuang D; Coryell W
    Am J Psychiatry; 1993 Aug; 150(8):1182-8. PubMed ID: 8328561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
    Weiser M; Levi L; Burshtein S; Hagin M; Matei VP; Podea D; Micluția I; Tiugan A; Păcală B; Grecu IG; Noy A; Zamora D; Davis JM
    J Clin Psychiatry; 2017 Jul; 78(7):e758-e765. PubMed ID: 28541645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interictal psychoses in comparison with schizophrenia--a prospective study.
    Tadokoro Y; Oshima T; Kanemoto K
    Epilepsia; 2007 Dec; 48(12):2345-51. PubMed ID: 17666070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
    Conley RR; Mahmoud R
    Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of psychotic bipolar disorder, schizoaffective disorder, and schizophrenia: an international, multisite study.
    Tondo L; Vázquez GH; Baethge C; Baronessa C; Bolzani L; Koukopoulos A; Mazzarini L; Murru A; Pacchiarotti I; Pinna M; Salvatore P; Sani G; Selle V; Spalletta G; Girardi P; Tohen M; Vieta E; Baldessarini RJ
    Acta Psychiatr Scand; 2016 Jan; 133(1):34-43. PubMed ID: 26096273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms.
    Poyurovsky M; Glick I; Koran LM
    J Psychopharmacol; 2010 Jun; 24(6):861-6. PubMed ID: 19074541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: the significance of symptoms, neuropsychological performance and cognitive biases.
    Andreou C; Roesch-Ely D; Veckenstedt R; Bohn F; Aghotor J; Köther U; Pfueller U; Moritz S
    Psychiatry Res; 2013 Dec; 210(3):729-34. PubMed ID: 23998362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.